SCHEMBL3058882

SCHEMBL3058882

CCN(CC)c1ccc(CNc2ccc(N(C)C)cc2)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.73
CA1 P00915 1/20 0.59
CA2 P00918 1/20 0.59
CA9 Q16790 1/20 0.59
ALDH1A1 P00352 6/20 0.57
MAPT P10636 5/20 0.57
NPC1 O15118 4/20 0.57
RAB9A P51151 3/20 0.57
L3MBTL1 Q9Y468 3/20 0.57
PANK3 Q9H999 1/20 0.53
KMT2A Q03164 4/20 0.52
LMNA P02545 3/20 0.52
HTT P42858 2/20 0.52
GFER P55789 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
KDM4E B2RXH2 2/20 0.52
MEN1 O00255 2/20 0.52
TP53 P04637 1/20 0.52
NOS1 P29475 1/20 0.51
MAPK1 P28482 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856237 0.89 CA1 (0.70) CNR2CA1CA2CA9ALDH1A1
SCHEMBL3047826 0.86 CNR2 (0.73) CNR2CA1CA2CA9ALDH1A1
SCHEMBL15087675 0.86 CNR2 (0.73) CNR2CA1CA2CA9ALDH1A1
SCHEMBL855663 0.86 ALDH1A1 (0.64) CNR2CA1CA2CA9ALDH1A1
SCHEMBL15064684 0.85 CNR2 (1.00) CNR2ALDH1A1MAPTNPC1RAB9A
SCHEMBL3058855 0.85 CNR2 (0.71) CNR2CA1CA2CA9ALDH1A1
SCHEMBL3067983 0.85 CNR2 (0.71) CNR2ALDH1A1MAPTNPC1L3MBTL1
Hydrochloric Acid SCHEMBL4736123 0.83 CNR2 (0.69) CNR2ALDH1A1MAPTNPC1L3MBTL1
Hydrochloric Acid SCHEMBL3069408 0.83 CNR2 (0.69) CNR2ALDH1A1MAPTNPC1L3MBTL1
SCHEMBL855265 0.83 CA1 (0.59) CNR2CA1CA2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100267697-A1 ION CHANNEL MODULATORS WYETH (US) 2010-10-21 US claimed
EP-2099754-A1 ION CHANNEL MODULATORS Wyeth a Corporation of the State of Delaware (US) 2009-09-16 EP claimed
EP-2091917-A1 ION CHANNEL MODULATORS Wyeth a Corporation of the State of Delaware (US) 2009-08-26 EP claimed
WO-2008073929-A1 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO claimed
WO-2008073934-A1 ION CHANNEL MODULATORS WYETH (US) 2008-06-19 WO claimed
US-20100267697-A1 ION CHANNEL MODULATORS WYETH (US) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267697-A1 ION CHANNEL MODULATORS CACNA1E, CACNA1A, CACNA1S CNR2 262/4885CA1 384/4885CA2 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.